Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PARP inhibitors in ovarian cancer: current status and future promise.

PARP inhibitors in ovarian cancer: current status and future promise. Gynecol Oncol. 2014 May; 133(2):362-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.